These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14600599)

  • 1. Evaluation of the patient with carcinoma of unknown origin metastatic to bone.
    Rougraff BT
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S105-9. PubMed ID: 14600599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation, prognosis, and medical treatment considerations of metastatic bone tumors.
    Brage ME; Simon MA
    Orthopedics; 1992 May; 15(5):589-96. PubMed ID: 1589351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal metastases of unknown origin: a retrospective analysis of 29 cases.
    Jacobsen S; Stephensen SL; Paaske BP; Lie PG; Lausten GS
    Acta Orthop Belg; 1997 Mar; 63(1):15-22. PubMed ID: 9151454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features of pathologically confirmed metastatic bone tumors--a report of 390 cases].
    Xu DL; Zhang XT; Wang GH; Li FB; Hu JY
    Ai Zheng; 2005 Nov; 24(11):1404-7. PubMed ID: 16552972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic strategy for bone and soft-tissue tumors.
    Simon MA; Finn HA
    Instr Course Lect; 1994; 43():527-36. PubMed ID: 9097183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACR appropriateness criteria on metastatic bone disease.
    Roberts CC; Daffner RH; Weissman BN; Bancroft L; Bennett DL; Blebea JS; Bruno MA; Fries IB; Germano IM; Holly L; Jacobson JA; Luchs JS; Morrison WB; Olson JJ; Payne WK; Resnik CS; Schweitzer ME; Seeger LL; Taljanovic M; Wise JN; Lutz ST
    J Am Coll Radiol; 2010 Jun; 7(6):400-9. PubMed ID: 20522392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of occult bone metastases: positron emission tomography.
    Peterson JJ; Kransdorf MJ; O'Connor MI
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S120-8. PubMed ID: 14600601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy.
    Rougraff BT; Kneisl JS; Simon MA
    J Bone Joint Surg Am; 1993 Sep; 75(9):1276-81. PubMed ID: 8408149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment for pathologic fracture.
    Wedin R
    Acta Orthop Scand Suppl; 2001 Jun; 72(302):2p., 1-29. PubMed ID: 11582636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic disease of the proximal femur.
    Faisham WI; Zulmi W; Biswal BM
    Med J Malaysia; 2003 Mar; 58(1):120-4. PubMed ID: 14556337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic bone disease: general principles, pathophysiology, evaluation, and biopsy.
    Frassica FJ; Gitelis S; Sim FH
    Instr Course Lect; 1992; 41():293-300. PubMed ID: 1588070
    [No Abstract]   [Full Text] [Related]  

  • 12. Occult prostate cancer detected by hyoid bone metastasis after resection of thyroglossal duct cyst.
    Wang SH; Lee JC; Liu TC
    Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1326-8. PubMed ID: 21601425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical metastatic lesions of the appendicular skeleton from tumors of known primary origin.
    Miric A; Banks M; Allen D; Feighan J; Petersilge CA; Carter JR; Makley JT
    J Surg Oncol; 1998 Apr; 67(4):255-60. PubMed ID: 9579374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of PET/CT in the evaluation of skeletal metastases.
    Kannivelu A; Loke KS; Kok TY; Osmany SY; Ali SZ; Suat-Jin L; Ng DC
    Semin Musculoskelet Radiol; 2014 Apr; 18(2):149-65. PubMed ID: 24715447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, location, and diagnostic evaluation of metastatic bone disease.
    Hage WD; Aboulafia AJ; Aboulafia DM
    Orthop Clin North Am; 2000 Oct; 31(4):515-28, vii. PubMed ID: 11043092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone metastasis revealing a primary prostate cancer].
    El Otmany A; Bouklata S; Hafid H; Chami I; Jalil A; Benjelloun S; Souadka A; Belabbas M
    J Radiol; 2000 Sep; 81(9):990-1. PubMed ID: 10992100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nuclear medicine in the diagnosis of cancer of unknown origin.
    Demir H; Berk F; Raderer M; Plowman PN; Lassen U; Daugaard G; Clausen M; Bohuslavizki KH; Peters M; Harmer C; Malamitsi J; Aktolun C
    Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):164-73. PubMed ID: 15243411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A solitary chest wall metastasis from unknown primary hepatocellular carcinoma.
    Hofmann HS; Spillner J; Hammer A; Diez C
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):557-9. PubMed ID: 12702916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chest wall metastases from unknown primary hepatocellular carcinoma.
    Qureshi SS; Shrikhande SV; Borges AM; Shukla PJ
    J Postgrad Med; 2005; 51(1):41-2. PubMed ID: 15793338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iodine-induced hyperthyroidism in metastatic thyroid carcinoma].
    Joseph U; Schmidt JA; Ehlenz K; Leppek R; Rothmund M; von Wichert P; Joseph K
    Dtsch Med Wochenschr; 1994 Nov; 119(46):1573-8. PubMed ID: 7956798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.